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 Social Science and Medicine (Revised, December 21, 2017; Finalised, February 3, 2018) 
 
The becoming of methadone in Kenya: How an intervention’s 
implementation constitutes recovery potential 
 
 
 
 
Abstract 
 
This analysis treats the recent introduction of methadone treatment in Kenya as a case of ‘evidence-
making intervention’. Using 30 qualitative interviews with people in receipt of methadone treatment 
in Nairobi, Kenya, methadone’s becoming is treated as an effect of its narrative and material 
implementations. The interviews are shown to enact a narrative of methadone recovery potential 
towards normalcy beyond addiction. Such recovery potential is materialised in practice through 
social interactions wherein methadone’s embodied effects are seen to be believed. Here, the 
recovering body affects others’ recovery potential. In a context of competing claims about 
methadone’s effects, including the circulation of doubt about experimenting with methadone 
treatment, embodied methadone effect helps moderate the multiverse of methadone knowledge. 
The material dynamics of methadone treatment delivery also affect its recovery potential, with the 
methadone queue enacting a rationing of recovery hope. Here, the experience of methadone’s 
implementation loops back to a life with drugs. I conclude that there is a coexistence of potentiality 
and actuality, a ‘methadone multiple’, produced through its narrative and material implementations.     
 
 
Keywords 
Kenya; Evidence-making intervention; Methadone; Recovery; Addiction; Assemblage  
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Introduction 
 
Methadone treatment is being introduced in Kenya as part of policy responses to control HIV 
transmissions linked to drug injecting (Rhodes et al., 2015a, 2016). Systematic reviews proffer such 
treatment as one of the best evidenced interventions for HIV prevention, linked to reductions in HIV 
infections and drug injecting risk practices as well as overdose and acquisitive crime (MacArthur et 
al., 2012). Such discourses of evidence-based intervention emphasise universal effect potential 
moderated in relation to context (Adams, 2008). In contrast, critical approaches do not separate 
knowledge from the practices of its making (Law, 2004). Here, the effects of methadone treatment 
are subject to the practices of its implementation (Rhodes et al., 2016). From this perspective, there 
is no single biomedical object of methadone intervening on a single biological body across an 
assumed boundary of context, and thus no single universe of evidence (Mol, 2002; Law, 2004). 
Rather, there is a multiplicity of methadone contingent on its local productions. In this article, I draw 
on qualitative interview accounts to explore the becoming of methadone treatment in Kenya. I 
concentrate on how practices of intervention implementation constitute recovery potential. 
 
Methadone can be appreciated as an object of the knowledge practices which enact it. In Europe 
and the West, methadone is generally cast as a treatment of drug withdrawal alleviation enabling 
individuals to exercise a freedom from addiction to live as normal citizens (Dole et al., 1966; 
Nettleton et al., 2013; Harris, 2015). Yet, there are markedly different versions of methadone 
possible. Policy discourses in Russia and parts of Eastern Europe, for example, constitute this same 
substance a toxic drug of addiction, a cause of criminality, and a failed addiction treatment of the 
West (Rhodes et al., 2010a). Similarly, the methadone produced in medical discourses as a 
treatment of pain relief is a different methadone, with distinct effects, to that produced in 
discourses of addiction (Keane, 2013). The technology of methadone treatment is subject to friction 
and shift, as seen in its various historical revisions as addiction recovery, harm reduction, HIV 
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prevention, and crime reduction (Berridge, 2012). While ‘post AIDS’ drug policies in parts of the 
West, such as the UK and US, are no longer framed by discourses of HIV emergency, and accordingly 
de-emphasise methadone as harm reduction in favour of addiction recovery, methadone in Kenya is 
promoted with international support as primarily a technology of HIV prevention (Rhodes et al., 
2015a). How the technology is enacted in policy as a solution to represented problems – HIV, 
addiction, crime – at once makes those problems and constitutes them as in need of addressing 
(Bacchi, 2009; Lancaster et al., 2017). Methadone is enacted as a resource through its material 
implementations. It therefore becomes necessary to ask of its enactments, what is methadone 
capacitated to do? 
 
Methadone’s representations are, of course, not separate from its material implementations. As 
Gomart (2002) has illustrated, the effects methadone performs are inextricably folded into its 
practices of implementation. Gomart explored the multiple meanings ascribed to methadone in 
different methadone trials, one in the USA in 1965 and one in France in 1975, showing how these 
trials produced opposing methadone effects. In one trial (USA), methadone was found to be 
different to heroin, and in the other (France), the effects produced between methadone and heroin 
were similar. Following the classic laboratory ethnographies of Latour and Woolgar (1986), Gomart 
finds that the properties of methadone, the substance itself, are produced through the particular 
relations of the trials. Rather than assumed to have an inherent or stable essence which is variously 
interpreted according to a given context (an approach adopted by mainstream implementation 
science), the “sheer multiplicity” of methadone meaning makes it “impossible to hold that the 
substance is constant”. Methadone’s evidence-making is inseparable from its practices (Rhodes et 
al., 2016).  
 
This accentuates attending to how an intervention’s implementation enacts its becoming. Attention 
accordingly shifts beyond representations alone (how meanings of methadone are made in 
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discourse) to the material assemblages of effects (human and non-human) which make-up an 
intervention and afford it capacity (Latour, 2005; Deleuze and Guattari, 1987). For instance, Fraser 
(2006) and Fraser and valentine (2008) illustrate how methadone’s implementations in Australia 
enable it to affect methadone consumption as a mode therapeutic and normalising conduct. One 
instance is how the material configurations of the methadone clinic, and the methadone queue 
especially, enact a sense of discipline upon its waiting patients, which in turn reproduces the trope 
of a problematic addict who is less-than deserving, less-than normal, and less-than citizen. Harris 
(2015), in her ethnography of how buprenorphine (another form of opioid substitute treatment) is 
constituted differently to methadone, also notes how the material implementation of the 
intervention energises, among its consuming subjects, its sense of recovery potential. She argues 
that detaching the delivery of the medicine (buprenorphine) from the physical space of the clinic (as 
with methadone’s delivery) enacts a sense of relative normalcy, underscored by the treatment being 
delivered by community-based pharmacists rather than by doctors. In addition, the physical effects 
of buprenorphine are felt by its users as ‘more normal’ than those of methadone’s ‘opiate feel’, and 
are thus afforded greater recovery potential. These studies push the focus of critique beyond that of 
how implementation science constitutes evidence-based intervention to tracing, empirically, an 
intervention’s evidencing and knowing as an effect of its implementation.  
 
A primary site in making methadone’s recovery potential is its enactment of normalcy. Addiction 
recovery discourses tend to portray overcoming addiction as a process of self-change and identity 
transformation, in which the spoiled addict identity is refashioned into a recovering self (Keane, 
2000; McIntosh and McKeganey, 2000). Personal narratives enact a recovery script, at once for self 
and in relation to others, to take account of past failings towards enabling a new, normal, and thus 
more socially acceptable, self no longer disrupted by addiction (Valverde, 2002; Keane, 2000; 
Jarvinen, 2004; Rhodes et al., 2010b). Here, addiction recovery is constituted as a promise of 
normalcy (Nettleton et al., 2013). The invention of methadone itself was predicated on its capacity to 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
“block the abnormal reactions of addicts” to permit them “to live as normal citizens” (Harris, 2015: 
516; Dole et al., 1966: 304). The recovery potential afforded by the promise of normalcy has a 
normalising effect (Nettleton et al., 2013; Fraser and valentine, 2008). The apparatus of methadone 
treatment can be viewed as one element in a relation of governance, reorganising addicts as more 
productive, healthy and normal (Bourgois, 2000; Weinberg, 2000). Enacting the self as free-to-
choose to self-govern itself appropriately is a key resource in this becoming of more normal (Rose, 
1999; Foucault, 1991). With addiction troubling freedom and choice (Keane, 2002; Valverde, 2002), 
methadone’s recovery potential is indexed to its capacity to rid or moderate the body of its 
addictions.  
 
Yet methadone’s potential to capacitate the addicted body to recover is, as already noted, not merely 
a matter of narrative construction but of enactments in situated discursive-material implementations 
(Law, 2004). This accentuates methadone’s recovery potential as an effect of an assemblage of 
relations (Deleuze and Guattari, 1987); of connections between various social, affective and material 
forces which flow between, and thus make-up, both the objects of methadone and recovery (Duff, 
2014, 2016). For instance, Duff has explored recovery in relation to mental illness as a relational 
achievement, wherein the recovered body is enacted through the affective flows it encounters in its 
social and material relations. Sociality and social support feature strongly as resources enabling social 
inclusion, while other forces in the assemblage of recovery include places, objects and activities. 
Recovery potential is afforded through the capacity of bodies to affect and be affected (Deleuze, 
1992): “In its encounters, in each affective modulation, the recovering body takes on additional 
simple parts, both human and non-human, which enhance that body’s power of acting” (Duff, 2014: 
117). Methadone’s implementations potentiate instances of such affective flow.  
 
After two years of planning, and much anticipation among would-be patients, methadone treatment 
was introduced in Kenya in December 2014, as part of national policy initiatives to prevent HIV 
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(Rhodes et al., 2015a). Methadone treatment is being implemented via specifically tailored clinics in 
Nairobi and in the Coast Province. The programme is sponsored by the U.S. President's Emergency 
Plan for AIDS Relief (PEPFAR), through the Center for Disease Control and USAID and with 
implementation support from the University of Maryland (USA) and the United Nations Office of 
Drugs and Crime (UNODC). The designing-up of methadone treatment in Kenya involved policy 
officials and clinicians making field-visits to treatment programmes held-up as best practice 
examples internationally (including in neighbouring Tanzania) in combination with in-country 
guidance received from teams of international experts, overseen by the University of Maryland and 
CDC, and reviews of international evidence of methadone treatment’s harm reduction potential. The 
making of methadone treatment in Kenya may be viewed as an effect of ‘translocal’ assemblages in 
knowledge-making (McFarlane, 2011), incorporating multiple translations between various forms of 
knowledge and practice of methadone treatment. In these networks of knowledge translation, the 
methadone treatment programmes of neighbouring Tanzania are an important force, for they enact 
a virtual foundation of localised evidence-making, including in relation to the recovery potential of 
treatment (Ubuguyu et al., 2016; Tran et al., 2015). While the product of methadone treatment in 
Kenya might be traced as an effect of its multiple recent knowledge productions between science, 
policy and practice and among intervention engineers and technicians (Latour and Woolgar, 1986), 
its local making can also be traced through its material implementations in relation to the addicted 
body and among intervention users. As of now, there are approximately 600 people receiving 
methadone treatment in Nairobi (where this research took place). While the introduction of 
methadone treatment in Kenya is framed in policy and through international partnership as 
primarily a technology of HIV prevention, it is striking that this same intervention is primarily framed 
as a technology of addiction recovery and solution to the problem of addiction by people who use 
drugs (Rhodes et al., 2015a). The hope of recovery, and of desire for normalcy, feature strongly in 
would-be patients’ enactments of methadone expectation (Rhodes et al., 2015a,b). Now, two years 
after methadone’s implementation, I use the qualitative interview accounts produced by people in 
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receipt of methadone treatment to explore how an intervention’s implementation constitutes its 
recovery potential.    
 
Approach 
     
The analyses here adopt an ‘evidence-making intervention’ approach (Rhodes et al., 2016). Rather 
than evidencing known interventions as responses to given policy problems, the approach taken 
seeks to ask how such evidence, intervention and problem came to be. This perspective draws first, 
on the study of how representations of evidence-based intervention are made through discourses of 
policy and science (Bacchi, 2009), and second, on the study of how intervention knowledge and 
effects are made through the material practices of their implementation (Latour, 2005; Law and 
Hassard, 2005). The focus is intervention objects and effects as things in the making through their 
materialisations.  
 
This approach makes two assumptions. First, intervention objects and effects are constituted through 
the knowledges which enact them (Mol, 2002; Law, 2004). This troubles the imagined separation of 
evidence from practice as assumed in mainstream ‘evidence-based intervention’ approaches (Green, 
2000). Second, rather than a single universe of evidence, a multiverse of evidence is elucidated, 
assuming evidence and intervention multiplicities (Mol, 2002; Bacchi, 2009). Interventions, 
populations, contexts and scientific knowledge about them are not held constant, since their 
transformative effects arise through their recursive interactions. An ontology of multiplicity troubles 
the emphasis implementation science places on aiding the translation of an intervention object from 
evidence into practice by accentuating the multiple and contingent transformations of an 
intervention as an effect of its knowledge-making practices (Wood et al., 1998). Whereas ‘evidence-
based intervention’ approaches tend to imagine a stable intervention, with universal effect potential, 
the evidencing and constitution of interventions is treated as never fixed or stable but multiple, 
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contingent and local (Law, 2004). Taken together, interventions such as methadone treatment are 
fluid rather than fixed technologies which affect their capacities in relation to the assemblages of 
their situation (Law, 2004; Deleuze and Guattari, 1987).  
 
Following Deleuze and Guattari (1987), an assemblage is made-up of the relations and flows 
between objects and the effects these produce through their interactions. This helps notice how 
particular assemblage relations produce potentials in relation to their affordances of recovery (Duff, 
2016). Accordingly, the approach to empirical analysis here – which uses qualitative interview 
accounts – is attuned towards noticing affect, and more particularly, the capacity of objects and 
bodies to affect and to be affected through their encounters with other objects (Deleuze, 1992). A 
core related idea is of matter as a process of becoming. For Deleuze, becoming is a transformative 
effect of the in-between relations and coming together of connections in assemblages. Methadone’s 
becoming is not fixed but affected by its particular assemblage relations.     
 
Methods 
This analysis is made through 30 qualitative interviews conducted with people in receipt of 
methadone treatment in Nairobi, Kenya. The broader study from which these analyses emanate 
explored participant accounts of their methadone treatment experience.
1
 Prior to this study, and in 
the two years proceeding methadone’s implementation, an emerging narrative of addiction recovery 
hope linked to methadone’s anticipated arrival had become noticeable (Rhodes et al., 2015a,b, 
2016). This analysis is attuned to these enactments, and accordingly seeks to trace the making of 
recovery potential through methadone treatment implementation practices, especially at the 
interface of treatment delivery and its use.  The study was undertaken with ethical approval from 
the University of Nairobi/Kenyatta National Hospital, London School of Hygiene and Tropical 
Medicine, and the University of California San Diego. All participants gave informed consent, and 
received a food parcel for their participation. All names used in this analysis are pseudonyms. 
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The data used for this analysis were generated by qualitative interviews conducted in a mix of 
Swahili and English by three researchers.
2
 These interviews were audio-recorded with informed 
consent for subsequent verbatim transcription and translation. Participant selection proceeded 
purposively, including in relation to: age (with six aged 25 or under); gender (nine women); and 
reported HIV status (16 reporting positive). The study inclusion criteria specified a minimum age of 
18 years (also the minimum age of methadone treatment entry at the time of the study), current 
engagement in methadone treatment, and a history of treatment of at least one month. Table 1 
summarises the study participants.  
 
Interviews were undertaken at a community-based drop-in centre for people who use drugs in 
Nairobi, which acted as a key referral point into methadone treatment. The city methadone clinic 
was purpose built to coincide with methadone’s implementation in December 2014 and is situated 
in the grounds of a hospital. While the interview data is used to bring to life the materialisation of 
methadone treatment, the capacity of this analysis to ‘emplace’ methadone’s materialisations in the 
space of the clinic is inevitably limited by its reliance on subjects’ accounts produced outside of this 
space. Interview data also presents particular challenges when seeking to notice affective and 
material relations (Coleman and Ringrose, 2013). The addition of an ethnographic element in the 
space of the clinic and in the moment of intervention delivery would have been an ideal 
complement to tracing how interviews enact their materialisation of treatment effect. It is also 
important to note how the space of the community-based drop-in may materialise the interviews in 
particularised ways. The community-based outreach project proffers an interface between the world 
of illicit drug use and the drug dens and people who inject drugs who desire or need methadone 
treatment. It enacts, in various ways, a device of translation towards the promise of normalcy 
through access to methadone treatment. In particular, there is strong advocacy of access to 
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methadone treatment by the community project on behalf of its clients, including constituting 
treatment referral as a means towards realising recovery promise.  
 
This analysis approaches interview data as relational to its situation of production, envisaging 
methadone’s recovery-making as an enactment of accounting performance (Bacchi and Bonham, 
2016). Interviews are thus treated not merely as texts representative of, or standing in for, practice, 
but as objects of practice and performance in the evidence-making of methadone intervention. 
Following Bacchi and Goodwin (2016: 32-36), this approach draws attention to “statements as 
‘things’ that have material form, rather than simply some comment made in conversation”, which 
“establish discourse in its ‘ponderous, awesome materiality’, bridging a symbolic-material division 
(Foucault 1972: 216)”. This view of narrative as practice with material form and effect allows for 
analysis of phenomena as patterned networks of relations and events, and of the complex 
mechanisms at work in the production of objects. Treating discourse as ‘things said’ focuses analysis 
on how certain things are rendered ‘sayable’, with certain constitutive effects. The analysis is also 
attuned to noticing the interplay of human and non-human elements in descriptions of recovery 
potential assemblage (Fox and Alldred, 2017). Taken together, rather than treating things for what 
they are, or for what they are represented to be, the focus is also on what such knowledge-making 
practices can do (Deleuze and Guattari, 1987). Tracing the enactment of methadone treatment as 
recovery potential, the analysis notices three main materialisations: narrative enactments of 
methadone as recovery; enactments of methadone as recovery in relation to a multiverse of 
methadone knowledge; and enactments of recovery hope as an effect of methadone delivery 
practices. 
 
Recovery potential 
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Methadone is enacted in interview accounts as a technology of drug withdrawal alleviation, enabling 
addiction recovery (“It clears withdrawals, and if you want to stop using drugs you will be able to 
stop”). In a context of repeated failed attempts to become drug-free through abstinence-oriented 
residential rehabilitation (see Rhodes et al., 2015b), methadone treatment is a hope for a recovered 
future: “Those who are taking it have changed. They are now clean. They are not injecting 
themselves. They do not have withdrawals” [Suleiman]; “Before I used to say like I will die soon, I 
won’t do anything. Like I have passed through the world. I came for nothing and I go for nothing, but 
now maybe I will do something” [Morris]. The recovery promise of methadone treatment extends 
beyond the physical management of drug withdrawals to a transformation of the self. Methadone is 
described as “clearing the mind” and “freeing” the self and body from its entanglement in a cycle of 
searching out street drugs to alleviate withdrawals. This opens up an altered way of being (“I didn’t 
know myself”; “I really changed”; “It makes me feel human”), with renewed future orientation and 
agency (“I think it can make me someone”; “I had lost hope in life”). Methadone promises freedom 
from addiction, and with this a future: 
 
You feel your mind has cleared, because before I never used to think about anything good about my 
life. I was just thinking about how I will get money, how I am going to steal. But when you take 
methadone, it clears your mind. You feel you want to be clean, and you want to take a shower, and 
you also get an appetite… Taking stuff just messes up your life, it takes you to the cemetery. But 
methadone clears your mind, and you start making or shaping your life. [Pendo] 
 
Fundamentally, methadone treatment promises normalcy: “I want to be like a normal person, to 
think the way a normal person thinks”; “I need to return to normal life and to be like other people”; 
“I changed back to a normal person, not an addict”. A key theme in this imagined state of normalcy 
is the restoration of social and familial relations: “I just want to start my family, like my wife and my 
children, so I want to work in a good job, so I can protect my family” [Morris]; “My family has started 
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to develop trust in me, even my mother. I have regained her trust. And even my dad” [Marvin]. The 
hope of re-inclusion through restoration of familial and social relations is a predominating theme:  
 
Methadone has helped a lot. It has changed me. People, right now, they can see my progress. My 
body has changed. People are happier around me. They call. People surround me, like my mother, my 
brother, telling me the difference of what methadone has done… It has made me recover. My family 
are happy now I am always with them. I have got time for my child, for my wife. [Oscar] 
 
It [methadone] has changed my life completely... People, they used to avoid me. They used to keep 
far from me. They wouldn’t come close to me. Friends, good friends, they are gone… My family, they 
are so happy about methadone. So far, it has changed me. They are happy for the methadone 
because they tell me they can see the changes. I have become a good person. [Morris]  
 
These narratives fuse together self-change with social acceptance. While the family is a core figure, 
this transformation extends beyond familial relations. Prominent in women’s accounts, for example, 
is the self before methadone as abject and outcast. This contrasts with a new self-with-methadone 
as clean, ordered, attractive, and accepted. One instance is methadone’s re-awakening of intimate 
and affective relations, including of the self as a sexual and desirable being, linked also to the hope 
of future partnerships and family life:  
 
Before methadone, he would think that I am going to infect him with lice, because I had a lot of them, 
and I used to have a bad smell. But now, I can even hug a person. The smell is gone. I don’t smell 
badly anymore… We met at the drug den. He told me he used to love me even then, but just because 
of the way I looked he couldn’t stand being with me. I was skinny and I looked like an old women. But 
you see me now, with methadone, you are looking good, and you have added weight, now I am 
willing to accept you, and share my life with you. [Pendo] 
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While the enactment of methadone’s recovery potential orientates to the future, beyond the 
recovery-in-the-making of the present, methadone’s embodied effects are felt and observable in the 
short-term. The self-transformations linked to methadone are “unbelievable”, defying the odds of 
expectation, and beyond comparison with previous addiction recovery efforts. Accounts invoke the 
“magic” of methadone, also positioning methadone treatment as “God’s work” (“God has helped us, 
and brought for us methadone”). There is a strong sense of gratitude to the technology, sometimes 
fused with particular thanks to Kenya’s President Uhuru: “Thank God and Uhuru for the way they 
have helped us. May Uhuru live long and serve as our president so that he can help many other 
people”.  
 
Recovery is a relational accomplishment 
Let us consider how the narrative of methadone’s recovery potential is enacted into experience. As 
with the accounts of Oscar and Morris above, these analyses emphasise that bearing witness to 
change is at the root of recovery’s becoming. Recovery is constituted as an effect of others’ bearing 
witness to, and acknowledging, bodily-material change. As Morris says of his sense of family re-
inclusion: “My brother, when I started methadone, he saw me changing… He said you can come back 
home… My brother took me back because of the methadone”. Self-change is materialised in relation 
to others’ witnessing and remarking of it. As Pendo describes of the evidence-making of her recovery 
through community reaction: “Even women in the community started saying that they did not 
believe when they saw the changes in me. They even asked me whether I had a rich husband, and I 
tell them that God has helped me, and also something I am taking called methadone”.  
 
Methadone’s effects are seen to be believed, both as a materialisation of one’s own recovery as 
much as enabling others to realise theirs. Suleiman says that he “used to hear people talking about 
methadone” but that he “hadn’t decided to stop taking stuff”, but this changed when he “saw one of 
[his] friends who had joined methadone”. Likewise, Morris’s recovery was affected by bearing 
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witness to methadone’s embodied effects: “I saw my friend change through methadone… We are 
seeing the changes… He changed completely. So, I had to ask him where I can get the medication”. 
Importantly, embodied change affects recovery capacity in others:  
 
Everyone wanted to see what will happen after we take methadone, whether we are going to 
change… They get the urge to come and join methadone to be like me. They come for methadone 
because they saw one of their own change for the better. [Asha] 
 
The enactment of recovery potential through bearing witness is subject to the context of the 
witnessing occasion. Two dimensions appear to shape the robustness of recovery’s evidence-
making: the qualitative nature of the change being witnessed; and those doing the witnessing. The 
more dramatic the change that is witnessed, the more convincing the case that recovery has 
become. As Marvin describes: “They get shocked with the change in me. They wonder what 
happened to this guy… They even ask my mother what has happened to me… They see I have 
changed”. In this respect, accounts accentuate how once failed addicts, especially those most unruly 
and doubting of methadone, become key forces for potentiating recovery in others. As Asha 
comments above: “They come for methadone because they saw one of their own change for the 
better”. And as previous methadone doubters, such as Jemima, recounted: “We have seen how you 
are looking good, so we realised that we were being lied to [about methadone’s recovery 
potential]”.  
 
Moreover, those constituted as having the greatest capital in endorsing normalcy and in offering a 
gateway to social re-acceptance are the most critical in affording recovery’s becoming. As noted, a 
primary element here is the family, with family members especially important resources of recovery 
potential. As Pendo says of her recovery: “My mother was very happy… She just hugged me and 
cried when she saw the change in me, and how I was looking good. Even today she sometimes cries 
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when she looks at me and sees how different I am from the way I used to be”. Equally important, is 
that her once doubting sister endorses the witnessing of the transformations made, also 
accentuating these changes as beyond belief: “My sister lives in Mombasa with her family. I send 
them pictures and they don’t believe me. They, and even myself, don’t believe that I own a phone, 
that I can talk to them and send them my pictures”. 
 
Methadone is a moment towards recovery’s making 
An important dimension in the making of recovery’s potential is that methadone treatment is 
constituted as a moment towards normalcy. Methadone is “not for life”. Imagined normalcy is a 
state beyond methadone. Accounts present methadone treatment as having a “two year” end-point 
(“We were told two years”; “We should take it for two years”).
3
 Normalcy, treatment’s ultimate 
expectation, is being drug and methadone free, with treatment a “two year” count-down to drug-
free normalcy: “For fourteen months I have taken methadone. Then the remaining six months they 
start reducing the dosage, and then you stop”. To use methadone otherwise constitutes treatment 
as improper (see also below). Accordingly, there is active interest, and a sense of accomplishment, in 
having methadone doses reduced, with people sometimes agitating for smaller doses than their 
doctors recommend (“They have said that people should not reduce their methadone dosage, and 
you know, we are willing to stop taking it, and change our lives for the better”). 
 
Methadone danger, methadone doubt, and doing treatment well 
 
Methadone treatment is treated here as an object constituted variably and momentarily through its 
narrative and material implementations. How then, does the predominant narrative of methadone 
as recovery potential juggle with alternative versions of methadone, and how are these multiple 
versions of methadone negotiated in practice? 
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While for some early adopters, methadone was a realisation of hope that had been two years in the 
making (Rhodes et al., 2016), for others whether to “sign-up” to methadone treatment was 
characterised by ambivalence. In this respect, accounts constitute methadone as an experiment 
surrounded by competing perspective. Accounts making methadone questionable or harmful 
circulated in the drug dens, especially among those electing not to become “clients” of methadone 
and among drug (heroin) dealers. Here, methadone is a danger, even a potential killer, and an 
experimental treatment not to be trusted: “They were saying these people are doing research with 
us… We are going to die… Some people have already died… You will get paralysed”. As Arthur 
outlines, methadone’s negative effects were multiple: “If you take it you will not be able to father a 
child, you will not be able to perform again, and this will make your wife run away. Others say that if 
you take it, you may become mad. And if you are old it will make your internal organs malfunction. 
And that you have to take methadone until you die. And if you discontinue, you will experience 
many problems”. These were methadones to be doubted or feared. To “join” methadone conferred 
an engagement with risk. Those joining-up without delay emphasised that they had nothing to lose, 
like Lilian: “Before I started methadone I still had problems. I didn’t have a place to live, so was 
sleeping outside. I had my children being cared for by my mother. I had a really bad life”.  
 
In consequence, it was common for some to hesitate on their uptake of treatment opportunity. We 
see at play here a friction in ways of making methadone – as a promised good, as a risk of harm – 
which to some extent enact the differentiated spaces of the drug den and the methadone clinic. 
Those deliberating these oscillating sites of representation – indeed, those enacting themselves as 
travelling from the world of drugs to methadone-assisted recovery – exercise a leap of faith in who 
and what to believe. A heightened reflexivity surrounds signing-up to an experimental project and to 
being that experiment: “I heard people saying that if you took methadone you will die. I didn’t know 
what would happen, I was afraid”. Most manage this friction by adopting a ‘wait and see’ policy, 
where methadone’s effects can be seen to materialise in those experimenting:  
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I joined later because I wanted to see what was happening to those who went on it earlier. I joined a 
bit later, when I saw those who had joined earlier, how some had recovered. I saw some of them 
changed. They are now clean and healthy. [Arthur] 
 
I didn’t know how methadone was going to react with me, so I decided to first see those who are 
taking methadone. You know, at the base [drug den] when people joined methadone most people 
were saying when you take methadone it is bad, so we became afraid, so we decided to wait and see 
what happens to those who are taking it… After watching him for three or four months I decided to 
come to this place. [Sulieman] 
 
Again, methadone’s recovery effects are seen (affected materially) to be believed. Bearing witness 
to embodied effect is a knowledge-practice which connects with, and helps moderate, that which is 
said or claimed: “People lie and say that methadone is killing… But if you follow doctors’ advice it will 
heal your mind, and that is what I believe, and that is what I have seen”. Pendo’s account brings 
together the dimensions of bearing witness to dramatic change which characterises methadone’s 
evidencing as recovery potential in the face of counter representations:  
 
A friend of mine, we used to sleep at the base, and he started methadone before us. He used to inject 
a lot of stuff, he was a heavy junky. Then he joined methadone. I watched him for a week, two weeks, 
a month… The funny thing was that he stopped injecting and taking stuff. He used to inject about 
eight stuff per session, but even on the first day he started methadone he completely stopped… He 
used to tell us, ‘Try it, you will see, it is a good thing’. I thought it was a joke. I started spying or 
checking out on him to know for sure, or check for real, he had stopped taking stuff and was on the 
methadone. I asked the woman who had rented us a place to sleep if she had ever seen this guy 
smoking or injecting himself, and she told me that even she is shocked because he is no longer the 
way he used to be. I wondered what happened, the way he used to love drugs like me. I decided to 
try it out.  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
18 
 
 
Whereas stories about methadone (what is represented) may be doubted as unstable, embodied 
methadone (what is actualised) is firmer knowledge connecting materially and viscerally with those 
witnessing. These moments in evidence-making are also afforded relative security and longevity 
since the embodiment of methadone as a good is located among former methadone doubters of the 
drug world. As Jemima indicates: “They say bad things, but they also came and joined when they saw 
how others who are using it had changed and were looking good”. Methadone knowledge affected 
through bodily interaction appears firmer, and feels more ‘real’, than representational knowledge 
claims. 
 
Messing with treatment 
Questionable versions of methadone treatment continue to circulate even once people have signed-
up as clients. A primary object of negotiation here concerns “mixing” (‘chakachua’ in Swahili); that is, 
whether and when methadone mixed with street drugs (especially heroin but also bhang)
4
 
constitutes improper treatment. Would-be patients of methadone are told by treatment providers 
at their initiation that mixing confers potential harm (“If you mix methadone with heroin we were 
told it makes you paralysed, or you can even die”). Rumours circulated as to the dangers of mixing 
(“Mixing bhang and methadone may have some bad side-effects later in life, and I thought I may 
become mad”). Accounts work to link good treatment conduct with avoidance of mixing and a focus 
on dose reduction towards a drug-free state of normalcy: 
 
I used to take 120ml, and they have been reducing me slowly. Now I am 70ml because I have been 
taking it for about one year. I want to continue like that until I get to zero. [Arthur] 
 
I have been taking it for one year and three months, and I haven’t mixed with anything. And I am the 
first person to get [methadone] who has never mixed it with anything. I was the one leading. Even 
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now, they have started reducing it for me… Yes, they are reducing it for me so that I don’t take heroin 
or methadone. I want to be just like any other human being who is not on drugs. [Pendo]   
 
Those routinely mixing are derided as “junkies” by proper clients of treatment, for they remain 
entrapped by the relentless search for a high (despite methadone’s effects making this difficult) 
rather than switching to a mission of recovery-making: “Methadone hasn’t helped them, but it is 
because they were mixing with bhang and heroin and alcohol”; “Those who are mixing, it is because 
they are greedy… They just want to spend the whole day sedated. But for those who know the 
importance of taking methadone they do not mix, and they are making their life for the better”. 
Moreover, it is these same junkies, intent on messing with treatment, who are constituted as the 
makers of methadone as ineffectual or dangerous: “The junkies, they are the ones who were saying 
that thirty six people had died after taking methadone”. The primary exception to the rule that 
mixing denotes bad treatment conduct involved the early days of methadone dosing, where some 
recalibrated their dose with added heroin (and in two cases, diverted methadone) to enable the 
treatment to work, as therapeutically intended, to alleviate withdrawals: “They increased it to fifty, 
and that is when I started feeling good… I used to mix drugs every time I left the hospital….”. 
Learning to use methadone well was also a process of adaptation to expectations of drug effect, and 
to a new life without heroin: “The first days when I started I was feeling like methadone is not 
enough, and later I realised that it is not that it is not enough, it was all about my mind and how I 
was thinking about it”; “You are confused. You don’t know whether to belong to either the current 
[methadone] or the old life [before methadone]”.  
 
Here then, we see the constitution of methadone as a resource to recovery reproduced by a moral 
code of treatment conduct wherein doing treatment well avoids contamination from non-medical 
forms of substance use. Well-meaning good clients of methadone, whose accounts enact a mission 
of recovery, navigate this moral boundary through justification that their additional substance use is 
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momentary and therapeutically motivated, unlike junkie behaviour, thus neutralising any pejorative 
association. Accounts perform their recovery-making by separating the world of drugs from the 
world of therapy, yet ‘chakachua’ constitutes a flow of effect between them.           
 
Rationing recovery hope and the methadone queue 
 
The methadone of recovery potential also oscillates in relation to an emergence of rationed recovery 
hope in practice. Here, I consider methadone’s implementation as a material dynamic in recovery’s 
rationing, illustrated through the particular case of the methadone delivery queue (see also, Fraser, 
2006).  
 
Methadone is dispensed within a tightly guarded window of operation between 7am and 1pm. 
There is no lee-way, and the gate to the hospital site is closed by a guard exactly on time. Each client 
receives their daily supervised dose through a single dispensing window. They are assigned a 
number on their arrival at the gate which places them in the daily methadone queue. The queue is 
characterised by hustle and bustle, and there are hundreds waiting: “We are about 150 and they 
serve us using one window”. The waiting can extend to hours. The anxiety generated by not making 
the time-cut is intense given the embodied fear of drug withdrawals. There are multiple accounts of 
people not making the dispensing cut-off in time: “It is one o’clock, and they will close the window 
when you are just standing there, and refuse to give you your medicine”; “It was one minute to 
midday [the weekend closing time], and they sent him to the gate to get a number, yet he was at the 
gate and he was told that the [dispensing is] over… When they came back it was exactly midday. 
They closed the window, and this guy just cried”.  
 
The waiting against the anticipation of an upsurge of drug withdrawals produced by the methadone 
queue connects back materially – through sensory memory – to scoring street drugs. It troubles the 
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recovering body by looping it back to a space from which it seeks detachment. As Lilian comments: 
“It is just like when you are using heroin, and you miss [your dose], your body suffers a lot… If they 
don’t give you your medicine […] they take you back to a place where you don’t want to go back to, 
you go back to smoking or sniffing heroin so that you can manage”. The methadone queue is a 
liminal space. With methadone constituted primarily as a technology of drug withdrawal alleviation, 
the methadone queue risks interfering with the recovery work being done. If late, and the 
dispensing window closes, there is the possibility of returning to the drug den to stave off 
withdrawals: “When you leave the clinic you decide to go to the den and spend some time there. 
After all, they have refused to give me methadone”. 
 
All participants talked of their concerns of being late for the methadone queue, or of making the 
queue on time but not making the dispensing cut off: “If you get there a bit late, with five minutes, 
they don’t give us methadone”; “You get there, like two minutes to time, and you are supposed to 
be given your medicine, but they don’t give you”. Some adopted the strategy of getting to the clinic 
as early as possible, often around 6am, an hour before the dispensing window is timed to open. For 
those with child care responsibilities, or with work, or who had to travel some distance by bus 
navigating Nairobi’s notorious traffic delays, getting to methadone on time resonates with the chaos 
and stress of a hustle. The queue itself becomes a disordered ordering, with arguments and 
sometimes violence ensuing between those queue-jumping and waiting.   
 
Lateness is punishable. Not only is not making the dispensing window in time marked by the 
prospect of drug withdrawal, those late feel disciplined, and if late on three occasions, are removed 
from the treatment, risking relapse. Accessing methadone enacts discipline upon its consuming 
subjects. There is disquiet that methadone’s delivery operates an unequal contract between clients 
and clinic. A common story, for instance, was that some clinic staff would open the dispensing 
window late: “They themselves, sometimes they are late. We were there by seven-thirty at the gate, 
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and even by eight the doctor was not yet there”; “They tell us to report at eight, and they report at 
nine. And when you come late, even by one minute, they will tell you to go back. And methadone 
was supposed to come to help us!”. A recurring story was that certain doctors would force a 
situation of waiting, intensifying anxiety, while reading a newspaper or drinking coffee in view of 
those waiting. For instance: 
 
At 6.30 you find around 100 clients have already arrived and registered their name at the counter. 
You find that the doctor comes in at around six but because it is a Saturday he won’t open the 
window. He will start by reading the newspaper until it is seven o’clock. He opens the window at 
around ten minutes past even though there are so many of us. Some people they are hot tempered, 
are furious, because they are held up. They were to be somewhere else. They arrived early so that 
they could go and attend to other issues. [Asha] 
 
The window is open and there is no doctor. If you peer in the window the doctor is in, and just seated 
either with the computer or reading the newspaper. We are many, and some of them want to go to 
work, others are taking care of their children, everyone has an issue to sort. They still take us as 
junkies. [Millie] 
 
The waiting for methadone against the heightened sense of withdrawal potential, combined with a 
sense of discipline and of being less than deserving, enacts – daily – a ‘not yet’ and ‘less than’ 
recovery. The methadone queue is less than separated from the world of the drug den: “They still 
take us as junkies”. For some, the methadone clinic experience is less than care: “It is only one 
doctor who does not look down on people. He takes us as human beings. But the others… They look 
down on us”. These patients have a weak sense of care entitlement, epitomised when their 
dispensing time runs out: “We have to beg them so that they can give us methadone”. Waiting and 
gratitude combine, enacting patient patients rather than therapeutic citizens (Rhodes et al., 2013). 
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Discussion and conclusions 
 
This analysis situates the object of methadone treatment as a fluid intervention. Methadone is 
multiple, open to negotiation, emerging from the discourses and practices which enact it. The 
becoming of methadone in Kenya is an effect of the social and material assemblages of its 
implementation. In exploring methadone’s becoming, I have concentrated on how its intervening 
capacitates recovery potential. To do this, I have drawn upon the qualitative interview accounts of 
participants in Nairobi who are new to using methadone. I draw attention to three concluding 
remarks concerning methadone recovery as an effect of its narration, affect and delivery.  
     
Narrative of methadone recovery 
Methadone is overwhelmingly narrated as an object of recovery potential. This narrative affords 
methadone the promise of normalcy. A primary definition of such normalcy is social acceptance and 
social inclusion, especially through restoring familial relations. There is nothing particularly new in 
this version of addiction recovery narrative, and it appears translocal (Nettleton et al., 2013; Harris, 
2015; McFarlane, 2011). It is possible that the hope incorporated into the substance of Kenya’s 
methadone through these accounts is intensified by a situation of rationed alternative drug 
treatment opportunity, the force of anticipation generated by methadone’s eagerly awaited arrival, 
and the immense gratitude that having this new technology affords (Rhodes et al., 2015a,b). But as 
with the narrative making of addiction recovery elsewhere (Keane, 2000; Valverde, 2002; Harris, 
2015), this is a technological solution affording the promise of freedom; from addiction, to choose, 
to become part of normal life. This narrative is a form of governance for the normalising effects it 
energises among its human subjects (Rose, 1999; Vrecko, 2010). Alternatively, normalcy can be 
noted as an embodied desire rather than simply imposed (Mol, 2002). The analysis here emphasises 
that it is the desire for normalcy, to move beyond addiction, to imagine a state of ‘more than’ drug 
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use, which gives methadone its local constitution. This is worthy of note because other versions of 
methadone are possible, and methadone can be made otherwise.  
 
There is striking similarity in the versions of methadone treatment made in Kenya to those made in 
other situations or places for pharmaceutically different opioid substitutes, such as buprenorphine in 
the U.S. (Harris, 2015). As we have seen, methadone is constituted to “clear the mind”, give “clarity” 
of thought, and “free” the self and body, accordingly enabling a new way of seeing and being. 
According to Harris (2015), all these same effects are claimed for buprenorphine in altogether 
different contexts (California), except that they are not claimed of methadone, which did not 
produce such clarity and freedom. Resonating with Gomart’s account of how the apparent same 
substance (methadone) produces fundamentally different materialised effects given the clinical trial 
relations and implementation practices producing them (2002), the substance of methadone is 
multiple, emergent according to local assemblages of need, desire and opportunity. Getting out of 
addiction as a pathway to normalcy is an enactment of Kenya’s methadone effect which is 
materialised, albeit to varying extent, through its implementations.  
 
Different circulating bodies of methadone knowledge connect with each other. New users to 
methadone in Kenya resource methadone as a medicine of recovery. This version of methadone 
connects with that materially implemented as part of a culture and system of addiction treatment 
giving primacy to abstinence and the articulation of the normal as drug-free. It also finds connection 
with versions of methadone treatment enacted in neighbouring Tanzania, where methadone’s 
implementation also energises recovery hope (Ubuguyu et al., 2016). Those signing-up to 
methadone’s experiment give emphasis to methadone as a state of transit beyond drugs. Treatment 
is described as a count-down to accomplishing normalcy constituted as being drug- and methadone-
free. Those mixing their methadone with drugs, or diverting from a mission of dose reduction, are 
messing with treatment as intended, and were sometimes derided for such junky-like behaviour. Yet 
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for all their flux, versions of methadone articulated elsewhere place considerably less expectation on 
being a resource for abstinence, instead anticipating normal life via a maintenance of drug 
substitution combined with HIV prevention and harm reduction (United Nations General Assembly, 
2006; Degenhardt et al., 2010). The methadone in Kenya enabled by its assemblage relations at the 
interface of treatment delivery and treatment use is also in friction with the methadone performed 
in national policy representations (NASCOP, 2013). Legitimised by HIV emergency, methadone 
enters Kenya as an experimental policy solution to the problem of HIV linked to drug injecting 
(Rhodes et al., 2015a). This articulation incorporates methadone treatment as part of globalised 
discourses of HIV concern and evidence-based HIV prevention (NASCOP, 2013; Degenhardt et al., 
2010; MacArthur et al., 2012). Methadone’s introduction into Kenya as a technology of HIV 
prevention is enabled by a complex apparatus of global institutions and investments. We find then, 
that methadone is multiple. Each of its seemingly singular instantiations is an effect of passing 
connection in a multiverse of circulating bodies of methadone knowledge enacted locally (Mol, 
2002; Law, 2004). Methadone treatment is far from a singular evidence-based intervention 
translated into multiple settings, but a local practice of emergent evidence-making interventions.  
 
Affect in the multiverse of methadone knowledge 
An important element in the assemblage relations affording methadone treatment its recovery 
potential is the affective flow produced through social interactions. Recovery is made through social 
interaction, with its embodied effects seen to be believed. Recovery’s constitution extends beyond a 
sense of mere self-change for it is materialised through its witnessing and reaction by others. It is 
this transmission of communication, this movement and connection between bodies, that is 
evidence-making of recovery’s becoming. Here, the recovering body is produced through an 
assemblage of social relations “of movement and rest” between interacting bodies (Deleuze and 
Guattari, 1987: 261). As these analyses show, not only is one’s own recovery enacted through being 
affected by its interactions with significant others, but the recovering body also produces affects 
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potentiating others’ recovery. This bearing witness to, and connecting with, embodied methadone 
effect is enacted in accounts as a critical and sustaining element of recovery’s making. It is actualised 
through variable forms of social connection, from the passing remarks and noticing of others to 
social re-acceptance in familial and social networks. In each instance, these interactions produce a 
relational movement, a transition, bringing recovery into being. We are reminded that “every small 
element matters in these ‘machinations’ (Rose, 1998) of bodies and affects: facial expressions, body 
movements, use of language, eye contact” (Zembylas, 2007).  It accentuates that it is through affect, 
and more particularly, the capacity of a body to affect and to be affected through its encounters 
with other bodies that the once ‘addict body’ is malleable to change. Affects constitute the body’s 
“power of acting” (Deleuze, 1992). They involve a “transfer of power, capacities or action-potential 
between bodies” (Deleuze, 1988: 48-50; Duff, 2014: 106).  
 
Recovery’s becoming can therefore be seen as fundamentally translated through its material and 
affective implementations. I arrive at this interpretation in part because the analysis has highlighted 
how different knowledge forms resource methadone’s recovery potential differently. While 
circulating stories about methadone (what is said and represented) conjured an atmosphere of 
uncertainty, as well as disquiet concerning the claimed harms of the methadone experiment, such 
knowledge was doubted when in friction with embodied methadone knowledge (what is actualised, 
witnessed and felt). Embodied methadone effects, transmitted materially and viscerally, seem to 
constitute a firmer, stickier, and more sustainable, knowledge; an evidence-making that is lived 
through the everyday of social interaction. This is evidence-making moving from the potential into 
the actual. Recovery, like any learning process, emerges through “practical engagement with lived-in 
environments” rather than through transmitted “propositional knowledge” linked to technological 
promise alone (Ingold, 2000: 168, 416). In this way, learning recovery is more practical than 
cognitive; it is a shift in perception that is “haptic – sensed, embodied, practised” (McFarlane, 2011: 
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21), which affords methadone its particular social transformations (such as enabling social 
acceptance through restoring familial and community relationships). 
 
Again, this coming together of different bodies of knowledge (representational, embodied) and the 
versions of methadone they produce (methadone as a harmful experiment, methadone as a 
recovery hope) accentuates a methadone multiverse. A multiverse is the synchronicity and friction 
between multiple certain and uncertain elements in a practice or reasoning (James, 1956), including 
the contradictory claims which surround new technologies (Leibing et al., 2016). In their account of 
stem cell research, Leibing et al (2016) illustrate that certainty in relation to new biotechnologies is 
made-up of knowledge gaps, ambivalence and doubt (Adams et al., 2009), a situation which parallels 
methadone’s experimentation in Kenya. There are two points here. First, methadone knowledge is 
produced out of the connections arising between its different, and sometimes competing, circulating 
bodies of knowledge. As we have seen, methadone doubt can be incorporated alongside a sense of 
embodied relative certainty. Second, if action is to be taken in a lived-in environment a platform of 
relative certainty must be enabled (Leibing et al., 2016). Here, the analyses underscore the relative 
weight of methadone’s embodied effects. We see this, for instance, when one’s repeated past 
recovery failures are cast by significant others as ‘false promises’ to doubt the proposition that this 
new medicine, methadone, will make a difference, and how pivotal methadone’s embodied 
materialisation becomes to disrupting or transforming this knowledge proposition. Likewise, we can 
see how the affective connections made through embodied methadone knowledge communicate 
across, and thus open-up, the bodily boundaries between the methadone doubters and the 
methadone users who affect recovery potential. Embodied methadone moderates its propositional 
doubt.   
 
Potentiality and actuality 
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Assemblages – the relations between objects that produce effects through their interactions – 
concentrate attention between the potential and actual (Duff, 2016; McFarlane, 2011). I have 
envisaged recovery potential linked to methadone treatment as a product of methadone’s 
representational and material implementations. Following Fraser (2006), I have highlighted how the 
apparatus of methadone’s delivery – illustrated by the methadone queue – enacts a rationing of 
recovery hope. Participants talked of ‘signing-up’ and ‘joining’ methadone, of signalling their 
recovery-making as a crossing to another side, of enacting a movement towards a new way of being 
in the world. This is methadone’s recovery potential, infused as we have seen with promise, hope 
and high expectation. The becoming of methadone’s recovery potential, however, is not straight-
forward. The material world is messy. We see oscillation, and collision, between the methadone 
represented and the methadone materialised. The methadone queue instantiates this friction. The 
enforced waiting against the anticipation of the upsurge of drug withdrawals, and the sense of 
discipline and weak entitlement to care, affects a sense of the methadone clinic as less than 
separated from the world of drugs. Practices of ‘chakachua’ – the messing of methadone treatment 
through its mixing with street drugs – also troubles a recovery reliant upon the performance of 
separation between the worlds of drugs and therapy. In different ways, the lived experience of 
methadone’s implementation loops back, including through embodied sensation, to a life with 
drugs. We see then, that this ‘methadone multiple’ – of potentiality, of actuality – is a liminality, a 
“living in two or more neighbouring worlds, worlds that overlap and coexist” (Mol and Law, 2002: 
8). The methadone queue is “coexistence at a single moment” (Mol and Law, 2002: 8). This 
multiverse of methadone speaks of its process of becoming, of its “inclusion of older value systems 
and practices in the construction of the present” (Bloch, 1991; Leibing et al., 2016: 439), and of 
different epistemic cultures coexisting within a field (Knorr-Cetina, 2006). 
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Andy Guise (Center for AIDS Research, University of California at San Diego). Data were generated 
through interviews undertaken by Emmy Kageha, James Ndimbii and Andy Guise. Fieldwork was 
supported through close collaboration with community outreach projects in Nairobi, especially the 
Nairobi Outreach Services Eastlands Team (NOSET). I am grateful to the participants in the study, 
and to Camron Duff for comments on an earlier draft. 
 
 
 
End Notes 
 
1. The analysis here draws on qualitative interview data generated by research supported by the 
University of California, San Diego, Center for AIDS Research (CFAR), an NIH-funded program (P30 
AI036214), which is supported by the following NIH Institutes and Centers: NIAID, NCI, NIMH, NIDA, 
NICHD, NHLBI, NIA, NIGMS, and NIDDK.  
 
2. This analysis uses data generated by qualitative interviews undertaken in a study of methadone and 
HIV care, on which Tim Rhodes was Co-Investigator, by: Emmy Kageha (University of Nairobi), James 
Ndimbii (Kenyan Consortium of Non-Government Organisations in AIDS), and Andy Guise (London 
School of Hygiene and Tropical Medicine and University of California at San Diego). 
 
3. It is unclear how the notion of a ‘two year’ timeframe for drug-free recovery emerged as a device of 
methadone’s implementation, although it seems the case that this idea is shared among intervention 
providers and users alike.  
 
4. Bhang marijuana, which is smoked.   
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Table 1 Study participants 
 
Pseudonym Gender Age Reported 
HIV status 
Income/Occupation 
Rob M 33 HIV + Unemployed 
Peter M 20 HIV - Student 
Oscar M 27 HIV - Unemployed 
Morris M 36 HIV - Disc Jockey 
Marvin M 24 HIV - Student 
Millie F 42 HIV - Peer Health Worker 
Freedom F 38 HIV - Casual labour 
Rahab F 40 HIV - Unemployed 
Webster M 34 HIV - Unemployed 
Fred M 50 HIV + Small business 
Ken M 34 HIV + Small business 
Yassin M 38 HIV + Florist 
Evans M 51 HIV - Unemployed 
Karanja M 38 HIV - Unemployed 
Steve M 42 HIV + Cobbler 
Philip M 24 HIV - Touting 
Alfred M 34 HIV + Washing cars 
Nesh M 19 HIV + Hustling 
Eric M 39 HIV - Touting 
Alan M 45 HIV - Casual labour 
Andrew M 30 HIV + Casual labour 
Winnie F 21 HIV + Unemployed 
Drake M 25 HIV + Touting 
Cathy F 29 HIV - Casual labour 
Lilian F 32 HIV - Unemployed 
Suleiman M 34 HIV + Unemployed 
Asha F 35 HIV + Unemployed 
Pendo F 38 HIV + Casual labour 
Jemima F 41 HIV + Casual labour 
Arthur M 50 HIV - Mechanic 
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RESEARCH HIGHLIGHTS 
• Treats methadone treatment in Kenya as effects of narrative and material implementations 
• Shows how qualitative interviews enact methadone treatment as recovery potential 
• Explores how methadone’s recovery potential is materialised in practice  
• Envisages a ‘methadone multiple’ in an ‘evidence-making intervention’ approach 
 
   
